Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19106543 | INTERFEROMETRIC NEAR INFRARED SPECTROSCOPY SYSTEM | February 2025 | November 2025 | Allow | 8 | 0 | 0 | No | No |
| 18646830 | BODY EXTREMITY TEMPERATURE CHANGE MONITORING SYSTEM AND METHOD | April 2024 | January 2026 | Allow | 21 | 1 | 0 | No | No |
| 18436777 | BLADDER VOLUME MEASURING DEVICE | February 2024 | January 2026 | Allow | 23 | 1 | 0 | No | No |
| 18412763 | Skin Marking Device | January 2024 | October 2025 | Allow | 21 | 1 | 1 | Yes | No |
| 18386412 | LIGHT ASSISTED NEEDLE PLACEMENT SYSTEM AND METHOD | November 2023 | May 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18495163 | ULTRASONIC WAVE GENERATION DEVICE | October 2023 | July 2025 | Allow | 21 | 0 | 0 | No | No |
| 18479138 | CONTACT-SURFACE DETERMINATION APPARATUS, ULTRASONIC DIAGNOSTIC APPARATUS, AND ULTRASONIC DIAGNOSTIC SYSTEM | October 2023 | September 2025 | Allow | 24 | 0 | 1 | Yes | No |
| 18474611 | ULTRASOUND PROBE AND ULTRASOUND DIAGNOSTIC APPARATUS | September 2023 | August 2025 | Allow | 23 | 1 | 0 | No | No |
| 18358330 | RAPID CALCULATION OF PARAMETERS FOR DELIVERING ULTRASOUND ENERGY TO SELECTED LOCATIONS IN THE BRAIN | July 2023 | October 2025 | Allow | 27 | 4 | 0 | Yes | No |
| 18039509 | NEURAL ACTIVITY CONTROLLED VIRTUAL REALITY SYSTEM | May 2023 | February 2026 | Abandon | 33 | 2 | 0 | No | No |
| 18096622 | DEVICE AND METHOD TO DETECT AND REMOVE BLOOD CLOTS FOR TREATMENT OF ISCHEMIC STROKE USING FORCE AND ELECTROMAGNETIC SENSING | January 2023 | March 2025 | Allow | 26 | 1 | 0 | No | No |
| 18083443 | METHOD FOR MULTIMODAL TISSUE IMAGING BASED ON RESONANCE RAMAN EFFECT ON METAL BASED MRI CONTRAST AGENTS AND METHOD FOR IONIZING LASER PLUMES THROUGH ATMOSPHERIC PRESSURE CHEMICAL IONIZATION | December 2022 | June 2025 | Abandon | 30 | 1 | 0 | No | No |
| 17856896 | NON-CONTACT RAPID EYE MOVEMENT (REM) MONITORING | July 2022 | May 2025 | Abandon | 34 | 0 | 1 | No | No |
| 17852067 | SYSTEMS AND METHODS FOR PATIENT MONITORING FOR RADIOTHERAPY | June 2022 | January 2024 | Allow | 19 | 2 | 0 | No | No |
| 17837900 | SYSTEMS AND METHODS FOR PATIENT MONITORING FOR RADIOTHERAPY | June 2022 | December 2025 | Abandon | 43 | 5 | 0 | No | No |
| 17726568 | HIGH-INTENSITY FOCUSED ULTRASOUND DEVICE AND METHOD FOR CONTROLLING TRANSDUCER MOVING PIEZOELECTRIC DEVICE USED IN THE SAME | April 2022 | March 2026 | Allow | 47 | 3 | 0 | Yes | No |
| 17692372 | ACTUATOR FOR ULTRASOUND TRANSDUCER | March 2022 | March 2025 | Allow | 36 | 1 | 0 | No | No |
| 17692618 | ULTRASONIC PROBE AND METHOD OF MANUFACTURING BACKING | March 2022 | July 2025 | Abandon | 40 | 4 | 0 | No | No |
| 17589137 | PULMONARY ARTERY CATHETER WITH ECHOCARDIOGRAPHY PROBE | January 2022 | December 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17648384 | SYSTEMS AND METHODS FOR REMOTE MOTOR ASSESSMENT | January 2022 | September 2025 | Abandon | 44 | 3 | 0 | Yes | No |
| 17646804 | INJECTION NEEDLE ASSEMBLY | January 2022 | May 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17442244 | A PATCH SENSOR FOR A MEDICAL DEVICE | September 2021 | January 2026 | Allow | 52 | 2 | 0 | No | Yes |
| 17441536 | ULTRASONIC PROBE AND ULTRASONIC IMAGING APPARATUS INCLUDING THE SAME | September 2021 | October 2023 | Allow | 24 | 1 | 0 | No | No |
| 17403390 | IMAGING SYSTEM AND METHOD WITH LIVE EXAMINATION COMPLETENESS MONITOR | August 2021 | May 2025 | Abandon | 45 | 4 | 0 | Yes | No |
| 17369495 | TUMOR ABLATION PLANNING USING INTERSTITIAL OPTICAL MAPPING | July 2021 | June 2025 | Allow | 48 | 5 | 0 | Yes | No |
| 17295127 | SENSOR FOR USE IN IMAGING APPLICATIONS | May 2021 | June 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17293239 | MEDICAL TOOL POSITIONING DEVICES, SYSTEMS, AND METHODS OF USE AND MANUFACTURE | May 2021 | July 2025 | Abandon | 50 | 3 | 1 | No | No |
| 17198668 | Automatic Identification, Notification And Guidance To Regions Of Interest In Ultrasound Images On Devices With Limited Display Area | March 2021 | January 2026 | Abandon | 58 | 6 | 0 | Yes | No |
| 17175707 | IMAGE-FREE ULTRASOUND FOR NON-INVASIVE ASSESSMENT OF EARLY VASCULAR HEALTH MARKERS | February 2021 | February 2024 | Abandon | 36 | 2 | 0 | Yes | No |
| 17254996 | ULTRASOUND-GUIDED ASSISTANCE DEVICE AND SYSTEM FOR NEEDLE | December 2020 | December 2023 | Abandon | 36 | 2 | 0 | No | No |
| 17058867 | System and Method for Proton and Phosphorus Magnetic Resonance Imaging | November 2020 | September 2025 | Allow | 57 | 3 | 1 | Yes | No |
| 17064928 | INTRACARDIAC CATHETER DEVICE AND METHODS OF USE THEREOF | October 2020 | December 2024 | Abandon | 50 | 3 | 0 | No | No |
| 17002793 | RADIOGRAPHIC IMAGE PROCESSING APPARATUS, RADIOGRAPHIC IMAGE PROCESSING METHOD, AND RADIOGRAPHIC IMAGE PROCESSING PROGRAM | August 2020 | March 2025 | Abandon | 55 | 4 | 0 | No | Yes |
| 16960306 | METHOD AND SYSTEM FOR IN VIVO DETECTION OF ADIPOSE TISSUE BROWNING | July 2020 | March 2024 | Abandon | 45 | 1 | 0 | No | No |
| 15733200 | Surgical Navigation System For Registering Coordinates of Patient-Customized Tool | June 2020 | February 2024 | Abandon | 44 | 3 | 0 | Yes | No |
| 16788499 | Cardiogram Measurements | February 2020 | April 2024 | Allow | 50 | 2 | 0 | Yes | No |
| 16779178 | MOTION, COMPRESSION, AND POSITIONING CORRECTIONS IN MEDICAL IMAGING | January 2020 | September 2024 | Allow | 56 | 4 | 1 | Yes | No |
| 16703481 | Dual-Mode Ultrasonic Assessment of Bone | December 2019 | November 2023 | Allow | 47 | 3 | 0 | Yes | Yes |
| 16572020 | ULTRASOUND DIAGNOSTIC APPARATUS | September 2019 | February 2026 | Allow | 60 | 6 | 0 | Yes | Yes |
| 16483620 | CARDIAC CATHETER WITH DEFORMABLE BODY | August 2019 | November 2025 | Allow | 60 | 7 | 0 | Yes | No |
| 16454855 | REGION OF INTEREST POSITIONING FOR LONGITUDINAL MONTIORING IN QUANTITATIVE ULTRASOUND | June 2019 | August 2025 | Abandon | 60 | 8 | 0 | Yes | No |
| 16421311 | SYSTEM AND METHOD FOR ASSESSMENT OF NEURO-INFLAMMATION USING MAGNETIC RESONANCE IMAGING (MRI) | May 2019 | January 2025 | Allow | 60 | 6 | 0 | Yes | Yes |
| 16316415 | SYSTEM AND METHOD FOR REMOTE DETECTION OF CARDIAC CONDITION | January 2019 | May 2024 | Abandon | 60 | 2 | 1 | No | No |
| 16303682 | MEDICAL OBSERVATION DEVICE, SUCH AS A MICROSCOPE OR AN ENDOSCOPE, AND METHOD USING A PSEUDO-COLOR PATTERN HAVING TEMPORAL AND/OR SPATIAL MODULATION | November 2018 | March 2024 | Abandon | 60 | 6 | 0 | Yes | No |
| 16100429 | IVUS AND EXTERNAL IMAGING TO MAP ANEURYSM TO DETERMINE PLACEMENT OF COILS AND LIKELIHOOD OF SUCCESS | August 2018 | March 2024 | Allow | 60 | 5 | 0 | No | Yes |
| 16100667 | REAL-TIME MONITORING OF FLUID FLOW WITH FLOW SENSING ELEMENT IN AN ANUERYSM AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | August 2018 | March 2024 | Allow | 60 | 7 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KOLKIN, ADAM D..
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 66.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner KOLKIN, ADAM D. works in Art Unit 3798 and has examined 25 patent applications in our dataset. With an allowance rate of 48.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.
Examiner KOLKIN, ADAM D.'s allowance rate of 48.0% places them in the 11% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by KOLKIN, ADAM D. receive 3.84 office actions before reaching final disposition. This places the examiner in the 96% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by KOLKIN, ADAM D. is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +20.8% benefit to allowance rate for applications examined by KOLKIN, ADAM D.. This interview benefit is in the 65% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 7.7% of applications are subsequently allowed. This success rate is in the 3% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 18.5% of cases where such amendments are filed. This entry rate is in the 22% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 24% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 71.4% of appeals filed. This is in the 60% percentile among all examiners. Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.